Systemic sclerosis (scleroderma) trials in Serbia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

  Where

  Belgrade, Kragujevac

  Age

  5 years to 80 years

  People

  1,072 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07691970
• Phase 2Taking people
  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Where

  Belgrade

  Age

  18 years and over

  People

  90 worldwide

  Run by

  Artiva Biotherapeutics, Inc.

  See details and how to joinNCT06991114 · EU 2025-520461-41-00